Available for the first time at Britain Against Cancer on 8 December are two new briefings from Cancer52: "Living with a rare or less...

A briefing on the implementation of Achieving World Class Outcomes: A Strategy for England 2015-2020.

A new report on patient group involvement in the new Patient and Clinical Engagement (PACE) process at the Scottish Medicines Consortium...

We are pleased to launch two new reports: our new patient experience report "Living for a rare or less common cancer, patient experiences...

We ran a very successful Social Media workshop on 12th November, with thanks to Celgene for their support. It was attended by 10 members...

Our thanks to Stopgap who have donated £400 to Cancer52. Stopgap is a small (50 people) owner managed business which finds marketing...

We are pleased to share the presentations delivered at the quarterly All Stakeholders Briefing on 21st October 2015 at the Royal College...

Chair Jonathan Pearce is interviewed on BBC Radio 4's Inside Health Programme on the Cancer Drug Fund and the extra challenges faced by...

Jonathan Pearce, Chair of Cancer52, said: "Cancer52 calls on NHS England to learn from The National Audit Office’s report[1] and ensure...

Cancer52 comment on Cancer Drug Fund announcement of 4 September 2015.